Ranjit Shahani
- All
- News
- Videos
-
Post Supreme Court verdict, Novartis to invest in India 'cautiously'
Swiss drugmaker Novartis AG will continue to invest in India, the vice chairman and managing director of the company said today after the Supreme Court dismissed the pharmaceutical major's plea for patent protection of its cancer drug Glivec.
-
Novartis on patent setback: Will continue to invest in India, but cautiously
Novartis India Limited, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
-
Post Supreme Court verdict, Novartis to invest in India 'cautiously'
Swiss drugmaker Novartis AG will continue to invest in India, the vice chairman and managing director of the company said today after the Supreme Court dismissed the pharmaceutical major's plea for patent protection of its cancer drug Glivec.
-
Novartis on patent setback: Will continue to invest in India, but cautiously
Novartis India Limited, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
